Abstract
This study has compared the incidence of adverse reactions to individual doses of thiacetazone of 150 mg, 225 mg, 300 mg, 375 mg, 450 mg, 525 mg and 600 mg with those reported with a placebo. The investigation was conducted “blind”, the patients and supervisory staff being unaware of the details of the experimental design and what any individual dose of medicament was, and the co-ordinator, also, was unaware of the latter. Adverse reactions were reported in 2. 3 per cent of 2589 doses of thiacetazone and 1.6 per cent of 568 doses of placebo, nearly all being mild. All the doses of thiacetazone studied were well tolerated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
